Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2022-04-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraosseous PRP for Knee Osteoarthritis: Pilot Study
NCT03160781
Analyzing Composition and Lubrication Properties of Synovial Fluid
NCT00912106
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
NCT02768155
Identification and Characterization of the Biomarker in Synovial Fluid for Hyaluronic Acid Therapy in Osteoarthritis
NCT01813916
High Frequency Intensive Autologous PRP Injection and Genicular Nerve Blocks in Treating Knee Osteoarthritis
NCT04088045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dextrose injection
Injection of 10 ml of 12.5% dextrose
Measuring synovial fluid components
Using speialized techniques to measure S.F. components
Hematopoietic stem cells
Injection of 10 ml of of 7.5 ml hematopoietic stem cells, 2 ml of 25% dextrose (5% diluted), 0.5 ml of 1% lidocaine (0.05% diluted),and 0.25 ml dexamethasone (1.5 mg)
Measuring synovial fluid components
Using speialized techniques to measure S.F. components
Platelet Rich Plasma injection
Injection of 10 ml of leukocyte rich platelet rich plasma
Measuring synovial fluid components
Using speialized techniques to measure S.F. components
No injection
Aspiration of synovial fluid may be an active comparator.
Measuring synovial fluid components
Using speialized techniques to measure S.F. components
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measuring synovial fluid components
Using speialized techniques to measure S.F. components
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High grade medial compartment cartilage loss ( Kellgren-Lawrence grade 3 or 4) on plain weight bearing X-ray
* Exposed subchondral bone at 110 degrees of flexion by ultrasound examination
* Easily visible suprapatellar pouch with quads conttraction.
Exclusion Criteria
* Current anticoagulation therapy
* Inflammatory or post-infectious knee arthritis
* Systemic inflammatory conditions
* Knee flexion less than 100 degrees
* Knee extension less than 165 degrees
* Valgus or varus more than 15 degrees
* Any knee injection in the precedign 3 months
* BMI more than 50 kg/ meter squared
* Gross synovial folds on ultrasound.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dharma Bioscience
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gastón Andres Topol
Treating physician and primary investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dharma Centro de Medicina Regenerativa
Rosario, Santa Fe Province, Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SFComponents#1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.